This trial is testing an app that could be used to quickly and easily measure a patient's flicker fusion frequency, which is important for diagnosing optic disorders.
1 Primary · 0 Secondary · Reporting Duration: 1/1/2020
2 Treatment Groups
eyeFusion Control Subjects
1 of 2
1 of 2
500 Total Participants · 2 Treatment Groups
Primary Treatment: eyeFusion · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 80 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many individuals have been invited to join this clinical trial?
"Confirmative, the particulars of this trial on clinicaltrials.gov indicate that it is currently accepting candidates. This research was initially launched on January 27th 2017 and edited most recently in July 4th 2022. The study requires 500 participants to enroll from 1 distinct medical facility." - Anonymous Online Contributor
Is this research open to individuals who are over four decades old?
"Researchers have identified that the acceptable age range for this clinical trial to be 18 - 80 years old." - Anonymous Online Contributor
To whom is participation in this trial available?
"Patients with scotoma, aged between 18 and 80 years old, are eligible to be enrolled in this medical experiment. The trial seeks 500 participants in total." - Anonymous Online Contributor
Is this trial still recruiting participants?
"Affirmative. According to information gathered from clinicaltrials.gov, this experiment was initially posted on January 27th 2017 and has been actively recruiting since then. The study is in search of 500 participants at one medical centre." - Anonymous Online Contributor